SEARCH

SEARCH BY CITATION

References

  • 1
    Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000; 174: 4762.
  • 2
    Mehal WZ, Azzaroli F, Crispe IN. Immunology of the healthy liver: old questions and new insights. Gastroenterology 2001; 120: 250260.
  • 3
    Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3: 5162.
  • 4
    Dikopoulos N, Jomantaite I, Schirmbeck R, Reimann J. Specific, functional effector/memory CD8+ T cells are found in the liver post-vaccination. J Hepatol 2003; 39: 910917.
  • 5
    Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman HD, Budd RC. Liver damage preferentially results from CD8+ T cells triggered by high affinity peptide antigens. J Exp Med 1998; 188: 11471157.
  • 6
    Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999; 163: 32023210.
  • 7
    Schirmbeck R, Böhm W, Ando K-I, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995; 69: 59295934.
  • 8
    Kuhröber A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, et al. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. J Immunol 1996; 156: 36873695.
  • 9
    Schirmbeck R, Böhm W, Reimann J. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific cytotoxic T lymphocytes in H-2d mice that reject syngeneic tumors. J Immunol 1996; 157: 35503558.
  • 10
    Böhm W, Mertens T, Schirmbeck R, Reimann J. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 1998; 16: 949954.
  • 11
    Schirmbeck R, Fissolo N, Chaplin P, Reimann J. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides. J Immunol 2003; 171: 12401246.
  • 12
    Reifenberg K, Lohler J, Pudollek HP, Schmitteckert E, Spindler G, Kock J, et al. Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice. J Hepatol 1997; 26: 119130.
  • 13
    Reifenberg K, Wilts H, Lohler J, Nusser P, Hanano R, Guidotti LG, et al. The hepatitis B virus X protein transactivates viral core gene expression in vivo. J Virol 1999; 73: 1039910405.
  • 14
    Schirmbeck R, Böhm W, Fissolo N, Melber K, Reimann J. Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen. Eur J Immunol 2003; 33: 24292438.
  • 15
    Trobonjaca Z, Leithäuser F, Moller P, Schirmbeck R, Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFNγ release by liver NKT cells. J Immunol 2001; 167: 14131422.
  • 16
    Trobonjaca Z, Kroger A, Stober D, Leithäuser F, Moller P, Hauser H, et al. Activating immunity in the liver. II. IFNβ attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J Immunol 2002; 168: 37633770.
  • 17
    Stober D, Schirmbeck R, Reimann J. IL-12/IL-18-dependent IFNγ release by murine dendritic cells. J Immunol 2001; 167: 957965.
  • 18
    Stober D, Trobonjaca Z, Reimann J, Schirmbeck R. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Eur J Immunol 2002; 32: 10991108.
  • 19
    Wagner M, Greten FR, Weber CK, Koschnick S, Mattfeldt T, Deppert W, et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 2001; 15: 286293.
  • 20
    Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 1727.
  • 21
    Barnden MJ, Allison J, Heath WR, Carbone FR. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 1998; 76: 3440.
  • 22
    Robertson JM, Jensen PE, Evavold BD. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J Immunol 2000; 164: 47064712.
  • 23
    Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 2002; 277: 4751747523.
  • 24
    McRae BL, Beilfuss BA, van Seventer GA. IFNβ differentially regulates CD40-induced cytokine secretion by human dendritic cells. J Immunol 2000; 164: 2328.
  • 25
    Wang X, Chen M, Wandinger KP, Williams G, Dhib-Jalbut S. IFNβ inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFNβ therapeutic effects in multiple sclerosis. J Immunol 2000; 165: 548557.
  • 26
    Biron CA. Interferons a and b as immune regulators—a new look. Immunity 2001; 14: 661664.
  • 27
    Bertolino P, Trescol BM, Rabourdin CC. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol 1998; 28: 221236.
  • 28
    Lee YC, Lu L, Fu F, Li W, Thomson AW, Fung JJ, et al. Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. Transplant Proc 1999; 31: 784.
  • 29
    Lechner F, Gruener NH, Urbani S, Uggeri J, Santantonio T, Kammer AR, et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000; 30: 24792487.
  • 30
    Lee AY, Manning WC, Arian CL, Polakos NK, Barajas JL, Ulmer JB, et al. Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA. HEPATOLOGY 2000; 31: 13271333.
  • 31
    Bertolino P, Bowen DG, McCaughan GW, Fazekas De St Groth B. Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol 2001; 166: 54305438.
  • 32
    Adib CM, Petit AF, Marie C, Fitting C, Cavaillon JM. Paradoxical priming effects of IL-10 on cytokine production. Int Immunol 1999; 11: 689698.
  • 33
    Mencacci A, Cenci E, Del-Sero G, Fe d'Ostiani C, Mosci P, Trinchieri G, et al. IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J Immunol 1998; 161: 62286237.
  • 34
    Segal BM, Glass DD, Shevach EM. IL-10-producing CD4+ T cells mediate tumor rejection. J Immunol 2002; 168: 14.
  • 35
    de Waal Malefyt R. IL-10. In: OppenheimJ, FeldmannM, eds. Cytokine Reference. New York: Academic Press, 2001: 165185.
  • 36
    Shibata Y, Foster LA, Kurimoto M, Okamura H, Nakamura RM, Kawajiri K, et al. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFNγ-inducing factors but enhances NK cell production of IFNγ. J Immunol 1998; 161: 42834288.
  • 37
    Cai G, Kastelein RA, Hunter CA. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFNγ when combined with IL-18. Eur J Immunol 1999; 29: 26582665.
  • 38
    Janssen-Timmen U, Dermietzel R, Frixen U, Leibstein A, Traub O, Willecke K. Immunocytochemical localization of the gap junction 26 K protein in mouse liver plasma membranes. EMBO J 1983; 2: 295302.
  • 39
    Niessen H, Willecke K. Strongly decreased gap junctional permeability to inositol 1,4, 5-trisphosphate in connexin32 deficient hepatocytes. FEBS Lett 2000; 466: 112114.
  • 40
    Schlitt HJ, Kanehiro H, Raddatz G, Steinhoff G, Richter N, Nashan B, et al. Persistence of donor lymphocytes in liver allograft recipients. Transplantation 1993; 56: 10011007.
  • 41
    Lüttig B, Pape L, Bode U, Bell EB, Sparshott SM, Wagner S, et al. Naive and memory T lymphocytes migrate in comparable numbers through normal rat liver: activated T cells accumulate in the periportal field. J Immunol 1999; 163: 43004307.
  • 42
    Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433442.
  • 43
    Bouwer HG, Bai A, Forman J, Gregory SH, Wing EJ, Barry RA, et al. Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect Immun 1998; 66: 28142817.
  • 44
    Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol 1999; 162: 65036509.
  • 45
    Klugewitz K, Topp SA, Dahmen U, Kaiser T, Sommer S, Kury E, et al. Differentiation-dependent and subset-specific recruitment of T-helper cells into murine liver. HEPATOLOGY 2002; 35: 568578.